RPG Life Sciences Q1FY22 PAT surges to Rs. 13.58 Cr

The company posted net profit of Rs.9.06 crores for the period ended June 30, 2020.

Astec Lifesciences 1FY22 consolidated PAT at Rs. 12.98 Cr

The company posted net profit of Rs.16.18 crores for the period ended June 30, 2020.

Glenmark Life Sciences IPO to open on July 27, 2021

The company proposes to utilise the net proceeds from the fresh issue towards payment of outstanding purchase consideration

Eris Lifesciences reports Q4FY21 consolidated net profit of Rs. 68.24 Cr

Eris Lifesciences has reported total income of Rs.1220.57 crores during the 12 months period ended March 31, 2021

RPG Life Sciences reports Rs. 6.92 crore PAT in Q4 FY2020-21

The company reported total income of Rs.390.05 crores during the 12 months period ended March 31, 2021

Glenmark Life Sciences files for IPO

The IPO comprises a fresh issue of up to Rs. 11,600 million and an offer for sale of up to 7,305,245 equity shares of Rs. 2 each of Glenmark Life Sciences by Glenmark Pharmaceuticals

SRM International Hand Conclave 2026 spotlights innovation and collaboration in hand rehabilitation

The conclave brought together over 1,000 delegates from across India and internationally

Pharma stocks face Q4 reality check amid global headwinds

Analysts expect modest revenue growth but pressure on profitability in the March quarter

Novartis CEO Vas Narasimhan joins Anthropic board

Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery

AWS unveils Amazon Bio Discovery to accelerate drug design with AI